UNLABELLED: Human cytomegalovirus is a widespread pathogen of major medical importance. It causes significant morbidity and mortality in the immunocompromised and congenital infections can result in severe disabilities or stillbirth. Development of a vaccine is prioritized, but no candidate is close to release. Although correlations of viral genetic variability with pathogenicity are suspected, knowledge about strain diversity of the 235kb genome is still limited. In this study, 96 full-length human cytomegalovirus genomes from clinical isolates were characterized, quadrupling the available information for full-genome analysis. These data provide the first high-resolution map of human cytomegalovirus interhost diversity and evolution. We show that cytomegalovirus is significantly more divergent than all other human herpesviruses and highlight hotspots of diversity in the genome. Importantly, 75% of strains are not genetically intact, but contain disruptive mutations in a diverse set of 26 genes, including immunomodulative genes UL40 and UL111A. These mutants are independent from culture passaging artifacts and circulate in natural populations. Pervasive recombination, which is linked to the widespread occurrence of multiple infections, was found throughout the genome. Recombination density was significantly higher than in other human herpesviruses and correlated with strain diversity. While the overall effects of strong purifying selection on virus evolution are apparent, evidence of diversifying selection was found in several genes encoding proteins that interact with the host immune system, including UL18, UL40, UL142 and UL147. These residues may present phylogenetic signatures of past and ongoing virus-host interactions. IMPORTANCE: Human cytomegalovirus has the largest genome of all viruses that infect humans. Currently, there is a great interest in establishing associations between genetic variants and strain pathogenicity of this herpesvirus. Since the number of publicly available full-genome sequences is limited, knowledge about strain diversity is highly fragmented and biased towards a small set of loci. Combined with our previous work, we have now contributed 101 complete genome sequences. We have used these data to conduct the first high-resolution analysis of interhost genome diversity, providing an unbiased and comprehensive overview of cytomegalovirus variability. These data are of major value to the development of novel antivirals and a vaccine and to identify potential targets for genotype-phenotype experiments. Furthermore, they have enabled a thorough study of the evolutionary processes that have shaped cytomegalovirus diversity.

Department of Experimental Virology Institute of Hematology and Blood Transfusion Prague Czech Republic

Department of Microbiology Iris Lab Brussels Belgium

Janssen Infectious Diseases BVBA Beerse Belgium

Laboratory of Clinical Virology Rega Institute for Medical Research Katholieke Universiteit Leuven Leuven Belgium

Metabolic Syndrome Research Center the 2nd Xiangya Hospital Central South University Changsha Hunan Chinad

Zobrazit více v PubMed

Cannon MJ, Schmid DS, Hyde TB. 2010. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20:202–213. doi:10.1002/rmv.655. PubMed DOI

Sinclair J, Reeves M. 2014. The intimate relationship between human cytomegalovirus and the dendritic cell lineage. Front Microbiol 5:389. doi:10.3389/fmicb.2014.00389. PubMed DOI PMC

Boeckh M, Geballe AP. 2011. Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest 121:1673–1680. doi:10.1172/JCI45449. PubMed DOI PMC

Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. 2013. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 26:86–102. doi:10.1128/CMR.00062-12. PubMed DOI PMC

Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R, National Vaccine Advisory Committee . 2004. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis 39:233–239. doi:10.1086/421999. PubMed DOI

Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA. 2013. Priorities for CMV vaccine development. Vaccine 32:4–10. doi:10.1016/j.vaccine.2013.09.042. PubMed DOI PMC

Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, Addison C, Dargan DJ, McGeoch DJ, Gatherer D, Emery VC, Griffiths PD, Sinzger C, McSharry BP, Wilkinson GW, Davison AJ. 2004. Genetic content of wild-type human cytomegalovirus. J Gen Virol 85:1301–1312. doi:10.1099/vir.0.79888-0. PubMed DOI

Murphy E, Shenk T. 2008. Human cytomegalovirus genome. Curr Top Microbiol Immunol 325:1–19. doi:10.1007/978-3-540-77349-8_1. PubMed DOI

Waner JL, Weller TH. 1978. Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera. Infect Immun 21:151–157. PubMed PMC

Drew WL, Sweet ES, Miner RC, Mocarski ES. 1984. Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis 150:952–953. doi:10.1093/infdis/150.6.952. PubMed DOI

Kilpatrick BA, Huang ES, Pagano JS. 1976. Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1. J Virol 18:1095–1105. PubMed PMC

Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, Hahn G, Nelson JA, Myers RM, Shenk TE. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A 100:14976–14981. doi:10.1073/pnas.2136652100. PubMed DOI PMC

Pignatelli S, Dal Monte P, Rossini G, Landini MP. 2004. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 14:383–410. doi:10.1002/rmv.438. PubMed DOI

Puchhammer-Stockl E, Gorzer I. 2006. Cytomegalovirus and Epstein-Barr virus subtypes—the search for clinical significance. J Clin Virol 36:239–248. doi:10.1016/j.jcv.2006.03.004. PubMed DOI

Puchhammer-Stockl E, Gorzer I. 2011. Human cytomegalovirus: an enormous variety of strains and their possible clinical significance in the human host. Future Virol 6:259–271. doi:10.2217/fvl.10.87. DOI

Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R. 1996. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 174:184–187. doi:10.1093/infdis/174.1.184. PubMed DOI

Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T. 1997. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 90:2097–2102. PubMed

Correia-Silva JF, Resende RG, Arao TC, Abreu MH, Teixeira MM, Bittencourt H, Silva TA, Gomez RS. 2011. HCMV gB genotype and its association with cytokine levels in hematopoietic stem cell transplantation. Oral Dis 17:530–537. doi:10.1111/j.1601-0825.2011.01801.x. PubMed DOI

Emery VC, Manuel O, Asberg A, Pang X, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A. 2012. Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy. J Clin Virol 54:56–60. doi:10.1016/j.jcv.2012.01.015. PubMed DOI PMC

Rossini G, Pignatelli S, Dal Monte P, Camozzi D, Lazzarotto T, Gabrielli L, Gatto MR, Landini MP. 2005. Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes. Microbes Infect 7:890–896. doi:10.1016/j.micinf.2005.01.016. PubMed DOI

Pignatelli S, Lazzarotto T, Gatto MR, Dal Monte P, Landini MP, Faldella G, Lanari M. 2010. Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae. Clin Infect Dis 51:33–41. doi:10.1086/653423. PubMed DOI

Paradowska E, Jablonska A, Studzinska M, Suski P, Kasztelewicz B, Zawilinska B, Wisniewska-Ligier M, Dzierzanowska-Fangrat K, Wozniakowska-Gesicka T, Czech-Kowalska J, Lipka B, Kornacka M, Pawlik D, Tomasik T, Kosz-Vnenchak M, Lesnikowski ZJ. 2013. Distribution of cytomegalovirus gN variants and associated clinical sequelae in infants. J Clin Virol 58:271–275. doi:10.1016/j.jcv.2013.05.024. PubMed DOI

Paradowska E, Jablonska A, Studzinska M, Kasztelewicz B, Zawilinska B, Wisniewska-Ligier M, Dzierzanowska-Fangrat K, Wozniakowska-Gesicka T, Kosz-Vnenchak M, Lesnikowski ZJ. 2014. Cytomegalovirus glycoprotein H genotype distribution and the relationship with hearing loss in children. J Med Virol 86:1421–1427. doi:10.1002/jmv.23906. PubMed DOI

Arav-Boger R, Willoughby RE, Pass RF, Zong JC, Jang WJ, Alcendor D, Hayward GS. 2002. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis 186:1057–1064. doi:10.1086/344238. PubMed DOI

Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS, Diener-West M, Landini MP. 2006. Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis 194:464–473. doi:10.1086/505427. PubMed DOI

Waters A, Hassan J, De Gascun C, Kissoon G, Knowles S, Molloy E, Connell J, Hall WW. 2010. Human cytomegalovirus UL144 is associated with viremia and infant development sequelae in congenital infection. J Clin Microbiol 48:3956–3962. doi:10.1128/JCM.01133-10. PubMed DOI PMC

Paradowska E, Jablonska A, Plociennikowska A, Studzinska M, Suski P, Wisniewska-Ligier M, Dzierzanowska-Fangrat K, Kasztelewicz B, Wozniakowska-Gesicka T, Lesnikowski ZJ. 2014. Cytomegalovirus alpha-chemokine genotypes are associated with clinical manifestations in children with congenital or postnatal infections. Virology 462–463:207–217. doi:10.1016/j.virol.2014.06.020. PubMed DOI

Arav-Boger R, Boger YS, Foster CB, Boger Z. 2008. The use of artificial neural networks in prediction of congenital CMV outcome from sequence data. Bioinform Biol Insights 2:281–289. PubMed PMC

He R, Ruan Q, Qi Y, Ma YP, Huang YJ, Sun ZR, Ji YH. 2006. Sequence variability of human cytomegalovirus UL146 and UL147 genes in low-passage clinical isolates. Intervirology 49:215–223. doi:10.1159/000091468. PubMed DOI

Heo J, Petheram S, Demmler G, Murph JR, Adler SP, Bale J, Sparer TE. 2008. Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children. Virology 378:86–96. doi:10.1016/j.virol.2008.05.002. PubMed DOI PMC

Pati SK, Pinninti S, Novak Z, Chowdhury N, Patro RK, Fowler K, Ross S, Boppana S, NIDCD CHIMES Study Investigators . 2013. Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection. Pediatr Infect Dis J 32:1050–1054. doi:10.1097/INF.0b013e31829bb0b9. PubMed DOI PMC

Nijman J, Mandemaker FS, Verboon-Maciolek MA, Aitken SC, van Loon AM, de Vries LS, Schuurman R. 2014. Genotype distribution, viral load and clinical characteristics of infants with postnatal or congenital cytomegalovirus infection. PLoS One 9:e108018. doi:10.1371/journal.pone.0108018. PubMed DOI PMC

Vales-Gomez M, Shiroishi M, Maenaka K, Reyburn HT. 2005. Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2. J Virol 79:2251–2260. doi:10.1128/JVI.79.4.2251-2260.2005. PubMed DOI PMC

Cerboni C, Achour A, Warnmark A, Mousavi-Jazi M, Sandalova T, Hsu ML, Cosman D, Karre K, Carbone E. 2006. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j. Eur J Immunol 36:732–741. doi:10.1002/eji.200425220. PubMed DOI

Sijmons S, Van Ranst M, Maes P. 2014. Genomic and functional characteristics of human cytomegalovirus revealed by next-generation sequencing. Viruses 6:1049–1072. doi:10.3390/v6031049. PubMed DOI PMC

Sijmons S, Thys K, Corthout M, Van Damme E, Van Loock M, Bollen S, Baguet S, Aerssens J, Van Ranst M, Maes P. 2014. A method enabling high-throughput sequencing of human cytomegalovirus complete genomes from clinical isolates. PLoS One 9:e95501. doi:10.1371/journal.pone.0095501. PubMed DOI PMC

Milne I, Stephen G, Bayer M, Cock PJ, Pritchard L, Cardle L, Shaw PD, Marshall D. 2013. Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinform 14:193–202. doi:10.1093/bib/bbs012. PubMed DOI

Katoh K, Standley DM. 2013. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 30:772–780. doi:10.1093/molbev/mst010. PubMed DOI PMC

Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78–83. PubMed PMC

Prichard MN, Penfold ME, Duke GM, Spaete RR, Kemble GW. 2001. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev Med Virol 11:191–200. doi:10.1002/rmv.315. PubMed DOI

Bradley AJ, Lurain NS, Ghazal P, Trivedi U, Cunningham C, Baluchova K, Gatherer D, Wilkinson GW, Dargan DJ, Davison AJ. 2009. High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169. J Gen Virol 90:2375–2380. doi:10.1099/vir.0.013250-0. PubMed DOI PMC

Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 30:2725–2729. doi:10.1093/molbev/mst197. PubMed DOI PMC

Wernersson R, Pedersen AG. 2003. RevTrans: multiple alignment of coding DNA from aligned amino acid sequences. Nucleic Acids Res 31:3537–3539. doi:10.1093/nar/gkg609. PubMed DOI PMC

Otto TD, Dillon GP, Degrave WS, Berriman M. 2011. RATT: Rapid Annotation Transfer Tool. Nucleic Acids Res 39:e57. doi:10.1093/nar/gkq1268. PubMed DOI PMC

Zhang G, Raghavan B, Kotur M, Cheatham J, Sedmak D, Cook C, Waldman J, Trgovcich J. 2007. Antisense transcription in the human cytomegalovirus transcriptome. J Virol 81:11267–11281. doi:10.1128/JVI.00007-07. PubMed DOI PMC

Gatherer D, Seirafian S, Cunningham C, Holton M, Dargan DJ, Baluchova K, Hector RD, Galbraith J, Herzyk P, Wilkinson GW, Davison AJ. 2011. High-resolution human cytomegalovirus transcriptome. Proc Natl Acad Sci U S A 108:19755–19760. doi:10.1073/pnas.1115861108. PubMed DOI PMC

Stern-Ginossar N, Weisburd B, Michalski A, Le VT, Hein MY, Huang SX, Ma M, Shen B, Qian SB, Hengel H, Mann M, Ingolia NT, Weissman JS. 2012. Decoding human cytomegalovirus. Science 338:1088–1093. doi:10.1126/science.1227919. PubMed DOI PMC

Szpara ML, Gatherer D, Ochoa A, Greenbaum B, Dolan A, Bowden RJ, Enquist LW, Legendre M, Davison AJ. 2014. Evolution and diversity in human herpes simplex virus genomes. J Virol 88:1209–1227. doi:10.1128/JVI.01987-13. PubMed DOI PMC

Benson G. 1999. Tandem Repeats Finder: a program to analyze DNA sequences. Nucleic Acids Res 27:573–580. doi:10.1093/nar/27.2.573. PubMed DOI PMC

Librado P, Rozas J. 2009. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25:1451–1452. doi:10.1093/bioinformatics/btp187. PubMed DOI

Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol 23:254–267. doi:10.1093/molbev/msj030. PubMed DOI

Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73:152–160. PubMed PMC

Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P. 2010. RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics 26:2462–2463. doi:10.1093/bioinformatics/btq467. PubMed DOI PMC

Bruen TC, Philippe H, Bryant D. 2006. A simple and robust statistical test for detecting the presence of recombination. Genetics 172:2665–2681. doi:10.1534/genetics.105.048975. PubMed DOI PMC

Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SDW. 2006. Automated phylogenetic detection of recombination using a genetic algorithm. Mol Biol Evol 23:1891–1901. doi:10.1093/molbev/msl051. PubMed DOI

Pond SL, Frost SD, Muse SV. 2005. HyPhy: hypothesis testing using phylogenies. Bioinformatics 21:676–679. doi:10.1093/bioinformatics/bti079. PubMed DOI

Delport W, Poon AF, Frost SD, Kosakovsky Pond SL. 2010. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics 26:2455–2457. doi:10.1093/bioinformatics/btq429. PubMed DOI PMC

Kosakovsky Pond SL, Frost SD. 2005. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol 22:1208–1222. doi:10.1093/molbev/msi105. PubMed DOI

Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond SL, Scheffler K. 2013. FUBAR: a fast, unconstrained Bayesian approximation for inferring selection. Mol Biol Evol 30:1196–1205. doi:10.1093/molbev/mst030. PubMed DOI PMC

Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. 2012. Detecting individual sites subject to episodic diversifying selection. PLoS Genet 8:e1002764. doi:10.1371/journal.pgen.1002764. PubMed DOI PMC

Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. doi:10.1002/jcc.20084. PubMed DOI

Cunningham C, Gatherer D, Hilfrich B, Baluchova K, Dargan DJ, Thomson M, Griffiths PD, Wilkinson GW, Schulz TF, Davison AJ. 2010. Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol 91:605–615. doi:10.1099/vir.0.015891-0. PubMed DOI PMC

Smith LM, McWhorter AR, Shellam GR, Redwood AJ. 2013. The genome of murine cytomegalovirus is shaped by purifying selection and extensive recombination. Virology 435:258–268. doi:10.1016/j.virol.2012.08.041. PubMed DOI

Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF. 2011. Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog 7:e1001344. doi:10.1371/journal.ppat.1001344. PubMed DOI PMC

Stanton R, Westmoreland D, Fox JD, Davison AJ, Wilkinson GW. 2005. Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients. J Med Virol 75:42–46. doi:10.1002/jmv.20235. PubMed DOI

Bradley AJ, Kovacs IJ, Gatherer D, Dargan DJ, Alkharsah KR, Chan PK, Carman WF, Dedicoat M, Emery VC, Geddes CC, Gerna G, Ben-Ismaeil B, Kaye S, McGregor A, Moss PA, Pusztai R, Rawlinson WD, Scott GM, Wilkinson GW, Schulz TF, Davison AJ. 2008. Genotypic analysis of two hypervariable human cytomegalovirus genes. J Med Virol 80:1615–1623. doi:10.1002/jmv.21241. PubMed DOI PMC

Lurain NS, Fox AM, Lichy HM, Bhorade SM, Ware CF, Huang DD, Kwan SP, Garrity ER, Chou S. 2006. Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts. Virol J 3:4. doi:10.1186/1743-422X-3-4. PubMed DOI PMC

Gorzer I, Guelly C, Trajanoski S, Puchhammer-Stockl E. 2010. Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J Virol 84:7195–7203. doi:10.1128/JVI.00475-10. PubMed DOI PMC

Murthy S, Hayward GS, Wheelan S, Forman MS, Ahn JH, Pass RF, Arav-Boger R. 2011. Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women. PLoS One 6:e15949. doi:10.1371/journal.pone.0015949. PubMed DOI PMC

Zhang J. 2000. Rates of conservative and radical nonsynonymous nucleotide substitutions in mammalian nuclear genes. J Mol Evol 50:56–68. http://link.springer.com/article/10.1007%2Fs002399910007. PubMed

Van Damme E, Van Loock M. 2014. Functional annotation of human cytomegalovirus gene products: an update. Front Microbiol 5:218. doi:10.3389/fmicb.2014.00218. PubMed DOI PMC

Stanton RJ, Baluchova K, Dargan DJ, Cunningham C, Sheehy O, Seirafian S, McSharry BP, Neale ML, Davies JA, Tomasec P, Davison AJ, Wilkinson GW. 2010. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest 120:3191–3208. doi:10.1172/JCI42955. PubMed DOI PMC

Cortese M, Calo S, D'Aurizio R, Lilja A, Pacchiani N, Merola M. 2012. Recombinant human cytomegalovirus (HCMV) RL13 binds human immunoglobulin G Fc. PLoS One 7:e50166. doi:10.1371/journal.pone.0050166. PubMed DOI PMC

Hannan AJ. 2012. Tandem repeat polymorphisms: mediators of genetic plasticity, modulators of biological diversity and dynamic sources of disease susceptibility. Adv Exp Med Biol 769:1–9. doi:10.1007/978-1-4614-5434-2_1. PubMed DOI

Gemayel R, Vinces MD, Legendre M, Verstrepen KJ. 2010. Variable tandem repeats accelerate evolution of coding and regulatory sequences. Annu Rev Genet 44:445–477. doi:10.1146/annurev-genet-072610-155046. PubMed DOI

Brouwer JR, Willemsen R, Oostra BA. 2009. Microsatellite repeat instability and neurological disease. Bioessays 31:71–83. doi:10.1002/bies.080122. PubMed DOI PMC

Duke GM, Osorio JE, Palmenberg AC. 1990. Attenuation of Mengo virus through genetic engineering of the 5′ noncoding poly(C) tract. Nature 343:474–476. doi:10.1038/343474a0. PubMed DOI

Hahn H, Palmenberg AC. 1995. Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their mengovirus counterparts. J Virol 69:2697–2699. PubMed PMC

Perdue ML, Garcia M, Senne D, Fraire M. 1997. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus Res 49:173–186. doi:10.1016/S0168-1702(97)01468-8. PubMed DOI

Bates PA, DeLuca NA. 1998. The polyserine tract of herpes simplex virus ICP4 is required for normal viral gene expression and growth in murine trigeminal ganglia. J Virol 72:7115–7124. PubMed PMC

Pfister LA, Letvin NL, Koralnik IJ. 2001. JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol 75:5672–5676. doi:10.1128/JVI.75.12.5672-5676.2001. PubMed DOI PMC

Kaufer BB, Jarosinski KW, Osterrieder N. 2011. Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation. J Exp Med 208:605–615. doi:10.1084/jem.20101402. PubMed DOI PMC

Davis CL, Field D, Metzgar D, Saiz R, Morin PA, Smith IL, Spector SA, Wills C. 1999. Numerous length polymorphisms at short tandem repeats in human cytomegalovirus. J Virol 73:6265–6270. PubMed PMC

Walker A, Petheram SJ, Ballard L, Murph JR, Demmler GJ, Bale JF Jr. 2001. Characterization of human cytomegalovirus strains by analysis of short tandem repeat polymorphisms. J Clin Microbiol 39:2219–2226. doi:10.1128/JCM.39.6.2219-2226.2001. PubMed DOI PMC

Picone O, Ville Y, Costa JM, Rouzioux C, Leruez-Ville M. 2005. Human cytomegalovirus (HCMV) short tandem repeats analysis in congenital infection. J Clin Virol 32:254–256. doi:10.1016/j.jcv.2004.10.012. PubMed DOI

Szpara ML, Tafuri YR, Parsons L, Shamim SR, Verstrepen KJ, Legendre M, Enquist LW. 2011. A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses. PLoS Pathog 7:e1002282. doi:10.1371/journal.ppat.1002282. PubMed DOI PMC

Vinces MD, Legendre M, Caldara M, Hagihara M, Verstrepen KJ. 2009. Unstable tandem repeats in promoters confer transcriptional evolvability. Science 324:1213–1216. doi:10.1126/science.1170097. PubMed DOI PMC

Martin P, Makepeace K, Hill SA, Hood DW, Moxon ER. 2005. Microsatellite instability regulates transcription factor binding and gene expression. Proc Natl Acad Sci U S A 102:3800–3804. doi:10.1073/pnas.0406805102. PubMed DOI PMC

Kawakami K, Salonga D, Park JM, Danenberg KD, Uetake H, Brabender J, Omura K, Watanabe G, Danenberg PV. 2001. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res 7:4096–4101. PubMed

Tiscornia G, Mahadevan MS. 2000. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol Cell 5:959–967. doi:10.1016/S1097-2765(00)80261-0. PubMed DOI

King DG, Soller M, Kashi Y. 1997. Evolutionary tuning knobs. Endeavour 21:36–40. doi:10.1016/S0160-9327(97)01005-3. DOI

Faux NG, Bottomley SP, Lesk AM, Irving JA, Morrison JR, de la Banda MG, Whisstock JC. 2005. Functional insights from the distribution and role of homopeptide repeat-containing proteins. Genome Res 15:537–551. doi:10.1101/gr.3096505. PubMed DOI PMC

Rupp B, Ruzsics Z, Buser C, Adler B, Walther P, Koszinowski UH. 2007. Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50. J Virol 81:5508–5517. doi:10.1128/JVI.02796-06. PubMed DOI PMC

Sharma M, Kamil JP, Coughlin M, Reim NI, Coen DM. 2014. Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells. J Virol 88:249–262. doi:10.1128/JVI.02358-13. PubMed DOI PMC

Sharma M, Bender BJ, Kamil JP, Lye MF, Pesola JM, Reim NI, Hogle JM, Coen DM. 2015. Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex. J Virol 89:523–534. doi:10.1128/JVI.02426-14. PubMed DOI PMC

Dargan DJ, Douglas E, Cunningham C, Jamieson F, Stanton RJ, Baluchova K, McSharry BP, Tomasec P, Emery VC, Percivalle E, Sarasini A, Gerna G, Wilkinson GW, Davison AJ. 2010. Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol 91:1535–1546. doi:10.1099/vir.0.018994-0. PubMed DOI PMC

Aoki T, Hirono I, Kurokawa K, Fukuda H, Nahary R, Eldar A, Davison AJ, Waltzek TB, Bercovier H, Hedrick RP. 2007. Genome sequences of three koi herpesvirus isolates representing the expanding distribution of an emerging disease threatening koi and common carp worldwide. J Virol 81:5058–5065. doi:10.1128/JVI.00146-07. PubMed DOI PMC

Sekulin K, Gorzer I, Heiss-Czedik D, Puchhammer-Stockl E. 2007. Analysis of the variability of CMV strains in the RL11D domain of the RL11 multigene family. Virus Genes 35:577–583. doi:10.1007/s11262-007-0158-0. PubMed DOI

Yu D, Silva MC, Shenk T. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A 100:12396–12401. doi:10.1073/pnas.1635160100. PubMed DOI PMC

Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, Liu F. 2003. Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A 100:14223–14228. doi:10.1073/pnas.2334032100. PubMed DOI PMC

Davison AJ, Akter P, Cunningham C, Dolan A, Addison C, Dargan DJ, Hassan-Walker AF, Emery VC, Griffiths PD, Wilkinson GW. 2003. Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes. J Gen Virol 84:657–663. doi:10.1099/vir.0.18856-0. PubMed DOI

Engel P, Perez-Carmona N, Alba MM, Robertson K, Ghazal P, Angulo A. 2011. Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production. Immunol Cell Biol 89:753–766. doi:10.1038/icb.2011.55. PubMed DOI

Gabaev I, Steinbruck L, Pokoyski C, Pich A, Stanton RJ, Schwinzer R, Schulz TF, Jacobs R, Messerle M, Kay-Fedorov PC. 2011. The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells. PLoS Pathog 7:e1002432. doi:10.1371/journal.ppat.1002432. PubMed DOI PMC

Shikhagaie M, Merce-Maldonado E, Isern E, Muntasell A, Alba MM, Lopez-Botet M, Hengel H, Angulo A. 2012. The human cytomegalovirus-specific UL1 gene encodes a late-phase glycoprotein incorporated in the virion envelope. J Virol 86:4091–4101. doi:10.1128/JVI.06291-11. PubMed DOI PMC

Powers C, DeFilippis V, Malouli D, Fruh K. 2008. Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325:333–359. doi:10.1007/978-3-540-77349-8_19. PubMed DOI

Dugan GE, Hewitt EW. 2008. Structural and functional dissection of the human cytomegalovirus immune evasion protein US6. J Virol 82:3271–3282. doi:10.1128/JVI.01705-07. PubMed DOI PMC

Maidji E, Tugizov S, Abenes G, Jones T, Pereira L. 1998. A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell-to-cell spread in polarized epithelial cells, colocalizes with the cytoskeletal proteins E-cadherin and F-actin. J Virol 72:5717–5727. PubMed PMC

Huber MT, Tomazin R, Wisner T, Boname J, Johnson DC. 2002. Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J Virol 76:5748–5758. doi:10.1128/JVI.76.11.5748-5758.2002. PubMed DOI PMC

Mandic L, Miller MS, Coulter C, Munshaw B, Hertel L. 2009. Human cytomegalovirus US9 protein contains an N-terminal signal sequence and a C-terminal mitochondrial localization domain, and does not alter cellular sensitivity to apoptosis. J Gen Virol 90:1172–1182. doi:10.1099/vir.0.008466-0. PubMed DOI

Noriega V, Redmann V, Gardner T, Tortorella D. 2012. Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 54:140–151. doi:10.1007/s12026-012-8304-8. PubMed DOI

Fielding CA, Aicheler R, Stanton RJ, Wang EC, Han S, Seirafian S, Davies J, McSharry BP, Weekes MP, Antrobus PR, Prod'homme V, Blanchet FP, Sugrue D, Cuff S, Roberts D, Davison AJ, Lehner PJ, Wilkinson GW, Tomasec P. 2014. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS Pathog 10:e1004058. doi:10.1371/journal.ppat.1004058. PubMed DOI PMC

Gurczynski SJ, Das S, Pellett PE. 2014. Deletion of the human cytomegalovirus US17 gene increases the ratio of genomes per infectious unit and alters regulation of immune and endoplasmic reticulum stress response genes at early and late times after infection. J Virol 88:2168–2182. doi:10.1128/JVI.02704-13. PubMed DOI PMC

Bronzini M, Luganini A, Dell'Oste V, De Andrea M, Landolfo S, Gribaudo G. 2012. The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells. J Virol 86:6875–6888. doi:10.1128/JVI.06310-11. PubMed DOI PMC

Davison AJ. 2011. Evolution of sexually transmitted and sexually transmissible human herpesviruses. Ann N Y Acad Sci 1230:E37–E49. doi:10.1111/j.1749-6632.2011.06358.x. PubMed DOI

Elde NC, Child SJ, Eickbush MT, Kitzman JO, Rogers KS, Shendure J, Geballe AP, Malik HS. 2012. Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell 150:831–841. doi:10.1016/j.cell.2012.05.049. PubMed DOI PMC

Brennan G, Kitzman JO, Rothenburg S, Shendure J, Geballe AP. 2014. Adaptive gene amplification as an intermediate step in the expansion of virus host range. PLoS Pathog 10:e1004002. doi:10.1371/journal.ppat.1004002. PubMed DOI PMC

McSharry BP, Avdic S, Slobedman B. 2012. Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation. Viruses 4:2448–2470. doi:10.3390/v4112448. PubMed DOI PMC

Yamamoto-Tabata T, McDonagh S, Chang HT, Fisher S, Pereira L. 2004. Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol 78:2831–2840. doi:10.1128/JVI.78.6.2831-2840.2004. PubMed DOI PMC

Poole E, Avdic S, Hodkinson J, Jackson S, Wills M, Slobedman B, Sinclair J. 2014. Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 secretion during latent infection through changes in the cellular microRNA hsa-miR-92a. J Virol 88:13947–13955. doi:10.1128/JVI.02424-14. PubMed DOI PMC

Prod'homme V, Tomasec P, Cunningham C, Lemberg MK, Stanton RJ, McSharry BP, Wang EC, Cuff S, Martoglio B, Davison AJ, Braud VM, Wilkinson GW. 2012. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18. J Immunol 188:2794–2804. doi:10.4049/jimmunol.1102068. PubMed DOI PMC

Chou SW. 1989. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. J Infect Dis 160:11–15. doi:10.1093/infdis/160.1.11. PubMed DOI

Haberland M, Meyer-Konig U, Hufert FT. 1999. Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J Gen Virol 80(Part 6):1495–1500. PubMed

Rasmussen L, Geissler A, Winters M. 2003. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J Infect Dis 187:809–819. doi:10.1086/367900. PubMed DOI

Faure-Della Corte M, Samot J, Garrigue I, Magnin N, Reigadas S, Couzi L, Dromer C, Velly JF, Dechanet-Merville J, Fleury HJ, Lafon ME. 2010. Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients. J Clin Virol 47:161–169. doi:10.1016/j.jcv.2009.11.023. PubMed DOI

Kolb AW, Ane C, Brandt CR. 2013. Using HSV-1 genome phylogenetics to track past human migrations. PLoS One 8:e76267. doi:10.1371/journal.pone.0076267. PubMed DOI PMC

Quinlivan M, Hawrami K, Barrett-Muir W, Aaby P, Arvin A, Chow VT, John TJ, Matondo P, Peiris M, Poulsen A, Siqueira M, Takahashi M, Talukder Y, Yamanishi K, Leedham-Green M, Scott FT, Thomas SL, Breuer J. 2002. The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis 186:888–894. doi:10.1086/344228. PubMed DOI

Santpere G, Darre F, Blanco S, Alcami A, Villoslada P, Mar Alba M, Navarro A. 2014. Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project. Genome Biol Evol 6:846–860. doi:10.1093/gbe/evu054. PubMed DOI PMC

Jung GS, Kim YY, Kim JI, Ji GY, Jeon JS, Yoon HW, Lee GC, Ahn JH, Lee KM, Lee CH. 2011. Full genome sequencing and analysis of human cytomegalovirus strain JHC isolated from a Korean patient. Virus Res 156:113–120. doi:10.1016/j.virusres.2011.01.005. PubMed DOI

Sauerbrei A, Wutzler P. 2007. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany. J Med Virol 79:1025–1031. doi:10.1002/jmv.20879. PubMed DOI

Norberg P, Tyler S, Severini A, Whitley R, Liljeqvist JA, Bergstrom T. 2011. A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One 6:e22527. doi:10.1371/journal.pone.0022527. PubMed DOI PMC

Lazzarotto T, Varani S, Gabrielli L, Pignatelli S, Landini MP. 2001. The tegument protein ppUL25 of human cytomegalovirus (CMV) is a major target antigen for the anti-CMV antibody response. J Gen Virol 82:335–338. PubMed

Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, Schall TJ. 1999. Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A 96:9839–9844. doi:10.1073/pnas.96.17.9839. PubMed DOI PMC

Ashiru O, Bennett NJ, Boyle LH, Thomas M, Trowsdale J, Wills MR. 2009. NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J Virol 83:12345–12354. doi:10.1128/JVI.01175-09. PubMed DOI PMC

Hakki M, Marshall EE, De Niro KL, Geballe AP. 2006. Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. J Virol 80:11817–11826. doi:10.1128/JVI.00957-06. PubMed DOI PMC

Jelcic I, Reichel J, Schlude C, Treutler E, Sinzger C, Steinle A. 2011. The polymorphic HCMV glycoprotein UL20 is targeted for lysosomal degradation by multiple cytoplasmic dileucine motifs. Traffic 12:1444–1456. doi:10.1111/j.1600-0854.2011.01236.x. PubMed DOI

Yang Z, Bjorkman PJ. 2008. Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor. Proc Natl Acad Sci U S A 105:10095–10100. doi:10.1073/pnas.0804551105. PubMed DOI PMC

Qi Y, Mao ZQ, Ruan Q, He R, Ma YP, Sun ZR, Ji YH, Huang Y. 2006. Human cytomegalovirus (HCMV) UL139 open reading frame: sequence variants are clustered into three major genotypes. J Med Virol 78:517–522. doi:10.1002/jmv.20571. PubMed DOI

Rasmussen L, Geissler A, Cowan C, Chase A, Winters M. 2002. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol 76:10841–10848. doi:10.1128/JVI.76.21.10841-10848.2002. PubMed DOI PMC

Hitomi S, Kozuka-Hata H, Chen Z, Sugano S, Yamaguchi N, Watanabe S. 1997. Human cytomegalovirus open reading frame UL11 encodes a highly polymorphic protein expressed on the infected cell surface. Arch Virol 142:1407–1427. doi:10.1007/s007050050169. PubMed DOI

Pignatelli S, Dal Monte P, Rossini G, Chou S, Gojobori T, Hanada K, Guo JJ, Rawlinson W, Britt W, Mach M, Landini MP. 2003. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 84:647–655. doi:10.1099/vir.0.18704-0. PubMed DOI

Lurain NS, Kapell KS, Huang DD, Short JA, Paintsil J, Winkfield E, Benedict CA, Ware CF, Bremer JW. 1999. Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol 73:10040–10050. PubMed PMC

Bar M, Shannon-Lowe C, Geballe AP. 2001. Differentiation of human cytomegalovirus genotypes in immunocompromised patients on the basis of UL4 gene polymorphisms. J Infect Dis 183:218–225. doi:10.1086/317939. PubMed DOI

Hayajneh WA, Contopoulos-Ioannidis DG, Lesperance MM, Venegas AM, Colberg-Poley AM. 2001. The carboxyl terminus of the human cytomegalovirus UL37 immediate-early glycoprotein is conserved in primary strains and is important for transactivation. J Gen Virol 82:1569–1579. PubMed

Ji YH, Rong Sun Z, Ruan Q, Guo JJ, He R, Qi Y, Ma YP, Mao ZQ, Huang YJ. 2006. Polymorphisms of human cytomegalovirus UL148A, UL148B, UL148C, UL148D genes in clinical strains. J Clin Virol 37:252–257. doi:10.1016/j.jcv.2006.09.007. PubMed DOI

Ji YH, Sun ZR, Ruan Q, He R, Qi Y, Ma YP, Huang YJ. 2006. High variability of human cytomegalovirus UL150 open reading frame in low-passaged clinical isolates. Chin Med Sci J 21:69–74. PubMed

Deckers M, Hofmann J, Kreuzer KA, Reinhard H, Edubio A, Hengel H, Voigt S, Ehlers B. 2009. High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55 genotyping with broad-range PCR. Virol J 6:210. doi:10.1186/1743-422X-6-210. PubMed DOI PMC

Autologous T-Cell-Free Antigen Presentation System Unveils hCMV-Specific NK Cell Response

Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene Loss

Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation